Michael D. Loberg, Director at IGM Biosciences, Inc. (IGMS), bought 12,175 shares at $19.62 ($228K) on 2022-09-29, disclosed to the SEC on 2022-10-03.
Open-market purchase of $228k IGMS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.62 | 5,821 | $114K | 50.0% |
| 2 | $19.62 | 5,821 | $114K | 50.0% |
| 3 | $0.00 | 533 | $0 | 0.0% |
| Total | $18.76 avg | 12,175 | $228K | 100% |
| Filing → |
| IGMS | BUY | 2019-09-20 | $93K | — | Filing → |
| ARQL | BUY | 2015-12-18 | $8K | — | Filing → |
| ARQL | BUY | 2015-12-17 | $3K | — | Filing → |